Sun Pharmaceuticals Industries Ltd Q1 FY2024-2025 Results: Summary

Revenue
₹13,185.30Cr
Net Profits
₹2,835.62Cr
Net Profit Margins
21.51%

Highlights

Revenue:

Sun Pharmaceuticals Industries Ltd’s revenue jumped 8.56% since last year same period to ₹13,185.30Cr in the Q1 2024-2025. On a quarterly growth basis, Sun Pharmaceuticals Industries Ltd has generated 4.74% jump in its revenue since last 3-months.

Net Profits:

Sun Pharmaceuticals Industries Ltd’s net profit jumped 40.2% since last year same period to ₹2,835.62Cr in the Q1 2024-2025. On a quarterly growth basis, Sun Pharmaceuticals Industries Ltd has generated 6.82% jump in its net profits since last 3-months.

Net Profit Margins:

Sun Pharmaceuticals Industries Ltd’s net profit margin jumped 29.14% since last year same period to 21.51% in the Q1 2024-2025. On a quarterly growth basis, Sun Pharmaceuticals Industries Ltd has generated 1.99% jump in its net profit margins since last 3-months.

FAQs

The revenue for Sun Pharmaceuticals Industries Ltd in the Q1 results 2024 was ₹13,185.30Cr.

The net profit for Sun Pharmaceuticals Industries Ltd in the Q1 results 2024 was ₹2,835.62Cr.

The net profit margin for Sun Pharmaceuticals Industries Ltd in the Q1 results 2024 was 21.51%.

The revenue for Sun Pharmaceuticals Industries Ltd in the Q1 results 2023 was ₹12,145.28Cr.

The net profit for Sun Pharmaceuticals Industries Ltd in the Q1 results 2023 was ₹2,022.54Cr.

The net profit margin for Sun Pharmaceuticals Industries Ltd in the Q1 results 2023 was 16.65%.